Lv, C.; Ren, C.; Yu, Y.; Yin, H.; Huang, C.; Yang, G.; Hong, Y.
Wentilactone A Reverses the NF-κB/ECM1 Signaling-Induced Cisplatin Resistance through Inhibition of IKK/IκB in Ovarian Cancer Cells. Nutrients 2022, 14, 3790.
https://doi.org/10.3390/nu14183790
AMA Style
Lv C, Ren C, Yu Y, Yin H, Huang C, Yang G, Hong Y.
Wentilactone A Reverses the NF-κB/ECM1 Signaling-Induced Cisplatin Resistance through Inhibition of IKK/IκB in Ovarian Cancer Cells. Nutrients. 2022; 14(18):3790.
https://doi.org/10.3390/nu14183790
Chicago/Turabian Style
Lv, Cuiting, Chunxia Ren, Yinjue Yu, Huijing Yin, Caiguo Huang, Gong Yang, and Yang Hong.
2022. "Wentilactone A Reverses the NF-κB/ECM1 Signaling-Induced Cisplatin Resistance through Inhibition of IKK/IκB in Ovarian Cancer Cells" Nutrients 14, no. 18: 3790.
https://doi.org/10.3390/nu14183790
APA Style
Lv, C., Ren, C., Yu, Y., Yin, H., Huang, C., Yang, G., & Hong, Y.
(2022). Wentilactone A Reverses the NF-κB/ECM1 Signaling-Induced Cisplatin Resistance through Inhibition of IKK/IκB in Ovarian Cancer Cells. Nutrients, 14(18), 3790.
https://doi.org/10.3390/nu14183790